Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries
Clinical trial NCT03080935 · TERMINATED
Trial details
- NCT number
- NCT03080935
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2022-03-04
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.